Macrophages Control the Bioavailability of Vitamin D and Vitamin D-Regulated T Cell Responses

The active form of vitamin D 3 (1,25(OH) 2 D 3 ) has a great impact on T cell effector function. Thus, 1,25(OH) 2 D 3 promotes T helper 2 (Th2) and regulatory T (Treg) cell function and concomitantly inhibits Th1 and Th17 cell function. Thus, it is believed that vitamin D exerts anti-inflammatory ef...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 12; p. 722806
Main Authors Lopez, Daniel Villalba, Al-Jaberi, Fatima A. H., Woetmann, Anders, Ødum, Niels, Bonefeld, Charlotte Menné, Kongsbak-Wismann, Martin, Geisler, Carsten
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 21.09.2021
Subjects
Online AccessGet full text
ISSN1664-3224
1664-3224
DOI10.3389/fimmu.2021.722806

Cover

Loading…
More Information
Summary:The active form of vitamin D 3 (1,25(OH) 2 D 3 ) has a great impact on T cell effector function. Thus, 1,25(OH) 2 D 3 promotes T helper 2 (Th2) and regulatory T (Treg) cell function and concomitantly inhibits Th1 and Th17 cell function. Thus, it is believed that vitamin D exerts anti-inflammatory effects. However, vitamin D binding protein (DBP) strongly binds both 1,25(OH) 2 D 3 and the precursor 25(OH)D 3 , leaving only a minor fraction of vitamin D in the free, bioavailable form. Accordingly, DBP in physiological concentrations would be expected to block the effect of vitamin D on T cells and dendritic cells. In the present study, we show that pro-inflammatory, monocyte-derived M1 macrophages express very high levels of the 25(OH)D-1α-hydroxylase CYP27B1 that enables them to convert 25(OH)D 3 into 1,25(OH) 2 D 3 even in the presence of physiological concentrations of DBP. Co-cultivation of M1 macrophages with T cells allows them to overcome the sequestering of 25(OH)D 3 by DBP and to produce sufficient levels of 1,25(OH) 2 D 3 to affect T cell effector function. This study suggests that in highly inflammatory conditions, M1 macrophages can produce sufficient levels of 1,25(OH) 2 D 3 to modify T cell responses and thereby reduce T cell-mediated inflammation via a vitamin D-mediated negative feed-back loop.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors share senior authorship
This article was submitted to Antigen Presenting Cell Biology, a section of the journal Frontiers in Immunology
Reviewed by: Gabriel Courties, INSERM U1183 Cellules Souches, Plasticité Cellulaire, Médecine Régénératrice Et Immunothérapies (INSERM), France; Antonio Ferrante, South Australia Pathology, Australia
Edited by: Elodie Segura, Institut Curie, France
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2021.722806